A Fatal Outcome of Rhino-orbito-cerebral Mucormycosis Following Tooth Extraction: A Case Report

Rhino-Orbito-Cerebral Mucormycosis: A Case Report and Review of the Literature

Rhino-orbito-cerebral mucormycosis is a rare, opportunistic and often fatal fungal infection usually occurring in immuno-compromised or diabetic patients. The treatment involves administration of Amphotericin B and surgical debridement. Due to its lethal nature, early recognition of the infection is essential. This paper reports a case of rhino-orbito-cerebral mucormycosis, which developed in a...

Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report

Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient – the need for prompt treatment

Mucormycosis is a rare life threatening fungal infection predominately seen in immunocompromised or diabetic patients. The following case is of a known type II diabetic patient who presented with sepsis and sudden unilateral loss of vision secondary to infective rhino-orbito-cerebral mucormycosis. Treatment of the condition required extensive surgical intervention and medical management for a l...

A prospective study of mucormycosis in north India: experience from a tertiary care hospital.

Mucormycosis is an emerging angioinvasive infection caused by the ubiquitous filamentous fungi of the Order Mucorales and class of Mucormycetes. We conducted a prospective study of 38 patients who were diagnosed as having mucormycosis in a tertiary care hospital during January 2010 to June 2011. The cases were analyzed regarding the site of involvement, underlying disease and species of fungi i...

Rhino-orbito-cerebral mucormycosis: a treatment dilemma.

A case of rhino-orbito-cerebral mucormycosis is presented showing its aggressive nature and progression of disease. The typical clinical features, neuroimaging and histological findings are highlighted in this report. Amphotericin B and surgical debridement remain the mainstay of treatment. However, associated co-morbidities need to be addressed.